Atea Pharmaceuticals, Inc. Common Stock (AVIR) stock analysis and AI prediction
The company facts of Atea Pharmaceuticals, Inc. Common Stock, with its price and AI prediction for the next 10 market days in SharePreds.
Keep looking in SharePreds
You have looked at today's stocks on this website. SharePreds shows every stock's likelihood of rising, its chart and how its earlier predictions ended, with alerts on the ones you follow.
See all five apps
About Atea Pharmaceuticals, Inc. Common Stock
Atea Pharmaceuticals Inc is a late-stage clinical biopharmaceutical company focused on the discovery, development, and commercialization of oral antiviral therapies for serious viral diseases. The company's pipeline includes a regimen of bemnifosbuvir and ruzasvir for the treatment of hepatitis C virus (HCV) infection and AT-587 for the treatment of hepatitis E virus (HEV) infection.
- Sector
- Healthcare
- Exchange
- NASDAQ
- Market value
- $315.6 million
- Size
- Small cap
- Employees
- 55
- Headquarters
- BOSTON, MA
- Listed since
- Oct. 30, 2020
- Website
- ateapharma.com
More Healthcare stocks
Other small cap stocks
Keep going
AVIR questions
What is the AI prediction for AVIR stock?
Each market day our model rates Atea Pharmaceuticals, Inc. Common Stock (AVIR) Bullish, Neutral or Bearish for the next 10 market days. Predictions are indicative: they rest on price and volume data, and they can be wrong.
How often is the AVIR prediction updated?
Each market day, Monday to Friday, except market holidays. The date of the prediction is shown beside it.
What do Bullish, Neutral and Bearish mean?
Bullish means the model sees a rise as likely over the next 10 market days, Bearish a fall, and Neutral no clear direction.
Where can I see the exact likelihood for AVIR?
In the SharePreds app for iPhone and Android, with the stock's chart, alerts on it and how its earlier predictions ended.
Where can I see AVIR options?
The AVIR options page explains its calls, puts and Greeks. The full AVIR options chain, every strike and expiry, is in the OpPreds app.